<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02688920</url>
  </required_header>
  <id_info>
    <org_study_id>15-007742</org_study_id>
    <nct_id>NCT02688920</nct_id>
  </id_info>
  <brief_title>Intraluminal Imaging of Duodenal Layer Morphometry in Patients With and Without Type 2 Diabetes</brief_title>
  <official_title>A Single-center, Observational, Intraluminal Imaging Study of Duodenal Layer Morphometry in Patients With and Without Type 2 Diabetes Undergoing Endoscopy of the Upper Gastrointestinal Tract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Victoria Gomez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study is conducted to determine how the duodenal layer thicknesses
      (mucosa, submucosa, and muscularis) vary with several factors in patients with and without
      type 2 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objectives

        1. To assess duodenal layer (mucosa, submucosa and muscularis) thickness differences
           between patients with and without type 2 diabetes using endoscopic ultrasound (EUS) and
           optical coherence tomography (OCT).

        2. To assess duodenal layer thickness differences between patients with type 2 diabetes.

        3. To assess duodenal layer thickness differences as a function of measurement location
           along the length of the duodenum.

        4. To compare measurements obtained by endoscopic ultrasound, to those obtained by optical
           coherence tomography.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thickness of the duodenal mucosa using OCT, and EUS if possible</measure>
    <time_frame>During imaging</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thickness of the duodenal submucosa using OCT if possible, and EUS</measure>
    <time_frame>During imaging</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Thickness of the duodenal muscularis using OCT if possible, and EUS</measure>
    <time_frame>During imaging</time_frame>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>With T2DM</arm_group_label>
    <description>Subjects with type 2 diabetes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without T2DM</arm_group_label>
    <description>Subjects without type 2 diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS and OCT imaging</intervention_name>
    <description>Intraluminal imaging using endoscopic ultrasound and endoscopic optical coherence tomography</description>
    <arm_group_label>With T2DM</arm_group_label>
    <arm_group_label>Without T2DM</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing previously scheduled routine endoscopy of the upper gastrointestinal
        tract.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is already scheduled for upper endoscopy with ultrasound or OCT, such as those
             with Barrett's esophagus.

          -  Patient is willing to sign an informed consent form.

        Exclusion Criteria:

          -  Patient is not a candidate for endoscopy, EUS, or OCT, such as those with strictures,
             inflammatory disease or previous anastomosis of the esophagus or duodenum.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victoria Gomez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248-256.e5. doi: 10.1016/j.amjmed.2008.09.041. Review.</citation>
    <PMID>19272486</PMID>
  </reference>
  <reference>
    <citation>Nagatake T, Fujita H, Minato N, Hamazaki Y. Enteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine. PLoS One. 2014 Mar 6;9(6):e90638. doi: 10.1371/journal.pone.0090638. eCollection 2014.</citation>
    <PMID>24603700</PMID>
  </reference>
  <reference>
    <citation>Haboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing. 1991 Jan;20(1):29-32.</citation>
    <PMID>2028847</PMID>
  </reference>
  <reference>
    <citation>Maluenda C, Phillips AD, Briddon A, Walker-Smith JA. Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy. J Pediatr Gastroenterol Nutr. 1984 Jun;3(3):349-56.</citation>
    <PMID>6737178</PMID>
  </reference>
  <reference>
    <citation>Rösch T, Lorenz R, Zenker K, von Wichert A, Dancygier H, Höfler H, Siewert JR, Classen M. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc. 1992 Jul-Aug;38(4):460-7.</citation>
    <PMID>1511822</PMID>
  </reference>
  <reference>
    <citation>Chang KJ, Katz KD, Durbin TE, Erickson RA, Butler JA, Lin F, Wuerker RB. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc. 1994 Nov-Dec;40(6):694-9.</citation>
    <PMID>7859967</PMID>
  </reference>
  <reference>
    <citation>Sivak MV Jr, Kobayashi K, Izatt JA, Rollins AM, Ung-Runyawee R, Chak A, Wong RC, Isenberg GA, Willis J. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest Endosc. 2000 Apr;51(4 Pt 1):474-9.</citation>
    <PMID>10744825</PMID>
  </reference>
  <reference>
    <citation>Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, Caristo ME, Vettor R, Castagneto M, Ghirlanda G, Mingrone G. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia. 2010 Oct;53(10):2233-40. doi: 10.1007/s00125-010-1830-9. Epub 2010 Jun 30.</citation>
    <PMID>20585935</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2016</study_first_posted>
  <last_update_submitted>September 16, 2017</last_update_submitted>
  <last_update_submitted_qc>September 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Victoria Gomez</investigator_full_name>
    <investigator_title>Gastroenterologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

